← Open Payments lookup

KIMBERLY MCCALPINE: Open Payments

NPI 1598156176 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,162 in 59 payments from 14 companies in 2025. Trend: 2023 $733 · 2024 $1,408 · 2025 $1,162

Food & beverage: $1,162
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC19$264
Madrigal Pharmaceuticals12$156
Takeda Pharmaceuticals U.S.A., Inc.6$145
Intercept Pharmaceuticals, Inc.1$125
Gilead Sciences, Inc.5$119
ABBVIE INC.6$114
Baxter Healthcare1$43
Mirum Pharmaceuticals, Inc.2$37
Merck Sharp & Dohme LLC1$35
Caris MPI, Inc.2$34

Products named: XIFAXAN, REZDIFFRA, LIVTENCITY, OCALIVA, TEFLARO, PERCLOT, Livmarli, KEYTRUDA.

Industry payments across TX — which companies pay providers there.